Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Zweifel, Christian ^a   Katan, Mira ^a   Schuetz, Philipp ^a   Siegemund, Martin ^a   Morgenthaler, Nils G ^b   Merlo, Adrian ^a   Mueller, Beat ^a,c   Christ Crain, Mirjam ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b THERMO FISHER SCIENTIFIC   (Germany)

^c Biotechnology Centre ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; GLYCOPEPTIDE; UNCLASSIFIED DRUG; COPEPTINS;

ACCURACY; ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD ANALYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MALE; MORTALITY; PREDICTION; PROGNOSIS; RANKIN SCALE; SURVIVAL RATE; FOLLOW UP; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; STATISTICS; TIME;

AGED; CEREBRAL HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; GLYCOPEPTIDES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77954036421     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-34     Document Type: Article

References (36)

1. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke; a journal of cerebral circulation 2009, 40(6):2068-2072.
2. Ariesen MJ, Algra A, Worp HB, Rinkel GJ. Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage. Journal of neurology, neurosurgery, and psychiatry 2005, 76(6):839-844. 10.1136/jnnp.2004.048223, 1739684, 15897508.
3. Alvarez-Sabin J, Delgado P, Abilleira S, Molina CA, Arenillas J, Ribo M, Santamarina E, Quintana M, Monasterio J, Montaner J. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke; a journal of cerebral circulation 2004, 35(6):1316-1322.
4. Sacco RL. Predicting stroke outcome: what does the 'stroke prognostocrit level' indicate?. Nature clinical practice 2006, 2(11):577. 10.1038/ncpneuro0345, 17057738.
5. Delgado P, Alvarez Sabin J, Montaner J. [Biological markers in spontaneous intracerebral hemorrhage]. Neurologia (Barcelona, Spain) 2007, 22(7):448-455.
6. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical chemistry 2006, 52(1):112-119. 10.1373/clinchem.2005.060038, 16269513.
7. Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends in endocrinology and metabolism: TEM 2008, 19(2):43-49. 10.1016/j.tem.2007.11.001, 18291667.
8. Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl 106:221-224. full_text, 19812953.
9. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Muller K, Meckel S, Gass A, Kappos L, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Annals of neurology 2009, 66(6):799-808. 10.1002/ana.21783, 20035506.
10. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J. The ABCs of measuring intracerebral hemorrhage volumes. Stroke; a journal of cerebral circulation 1996, 27(8):1304-1305.
11. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke; a journal of cerebral circulation 2004, 35(8):1941-1945.
12. Gill MR, Reiley DG, Green SM. Interrater reliability of Glasgow Coma Scale scores in the emergency department. Annals of emergency medicine 2004, 43(2):215-223. 10.1016/S0196-0644(03)00814-X, 14747811.
13. Mahoney FI, Barthel DW. Functional Evaluation: the Barthel Index. Maryland state medical journal 1965, 14:61-65.
14. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scottish medical journal 1957, 2(5):200-215.
15. Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke; a journal of cerebral circulation 2001, 32(4):891-897.
16. Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Martinez JJ, Gonzalez-Cornejo S. Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke; a journal of cerebral circulation 2007, 38(5):1641-1644.
17. Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B. Copeptin in the differential diagnosis of hyponatremia. The Journal of clinical endocrinology and metabolism 2009, 94(1):123-129. 10.1210/jc.2008-1426, 18984663.
18. Robertson GL. Antidiuretic hormone. Normal and disordered function. Endocrinology and metabolism clinics of North America 2001, 30(3):671-694. vii., 10.1016/S0889-8529(05)70207-3, 11571936.
19. Singh Ranger G. The physiology and emerging roles of antidiuretic hormone. International journal of clinical practice 2002, 56(10):777-782.
20. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. Journal of neuroendocrinology 2004, 16(4):348-355. 10.1111/j.0953-8194.2004.01172.x, 15089973.
21. Itoi K, Seasholtz AF, Watson SJ. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocrine journal 1998, 45(1):13-33. 10.1507/endocrj.45.13, 9625443.
22. Katan M, Morgenthaler N, Widmer I, Puder JJ, Konig C, Muller B, Christ-Crain M. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro endocrinology letters 2008, 29(3):341-346.
23. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock (Augusta, Ga) 2007, 28(2):219-226. 10.1097/SHK.0b013e318033e5da, 17515850.
24. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007, 115(16):2103-2110. 10.1161/CIRCULATIONAHA.106.685503, 17420344.
25. Stoiser B, Mortl D, Hulsmann M, Berger R, Struck J, Morgenthaler NG, Bergmann A, Pacher R. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. European journal of clinical investigation 2006, 36(11):771-778. 10.1111/j.1365-2362.2006.01724.x, 17032344.
26. Klose M, Juul A, Struck J, Morgenthaler NG, Kosteljanetz M, Feldt-Rasmussen U. Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study. Clinical endocrinology 2007, 67(4):598-606.
27. Vakili A, Kataoka H, Plesnila N. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2005, 25(8):1012-1019. 10.1038/sj.jcbfm.9600097, 15744246.
28. Molnar AH, Varga C, Berko A, Rojik I, Parducz A, Laszlo F, Laszlo FA. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia. Acta neurochirurgica 2008, 150(3):265-271. 10.1007/s00701-007-1400-1, 18288441.
29. Trabold R, Krieg S, Scholler K, Plesnila N. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice. Journal of neurotrauma 2008, 25(12):1459-1465. 10.1089/neu.2008.0597, 19118456.
30. Xu M, Su W, Huang WD, Lu YQ, Xu QP, Chen ZJ. Effect of AVP on brain edema following traumatic brain injury. Chinese journal of traumatology = Zhonghua chuang shang za zhi/Chinese Medical Association 2007, 10(2):90-93.
31. Gebel JM, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke; a journal of cerebral circulation 2002, 33(11):2636-2641.
32. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke; a journal of cerebral circulation 1993, 24(7):987-993.
33. Delgado P, Alvarez-Sabin J, Abilleira S, Santamarina E, Purroy F, Arenillas JF, Molina CA, Fernandez-Cadenas I, Rosell A, Montaner J. Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology 2006, 67(1):94-98. 10.1212/01.wnl.0000223349.97278.e0, 16832084.
34. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002, 58(4):624-629.
35. Delgado P, Alvarez Sabin J, Santamarina E, Molina CA, Quintana M, Rosell A, Montaner J. Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke; a journal of cerebral circulation 2006, 37(11):2837-2839.
36. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365(9457):387-397.